Use of complementary therapies by patients with IBD may indicate psychosocial distress.
about
Dietary factors in the modulation of inflammatory bowel disease activityHerbal and plant therapy in patients with inflammatory bowel diseaseBotanical Drugs as an Emerging Strategy in Inflammatory Bowel Disease: A ReviewSystematic review: the efficacy of herbal therapy in inflammatory bowel diseaseHerbal medicine in the treatment of ulcerative colitisEffects of Boswellia serrata in mouse models of chemically induced colitisUse of complementary and alternative medicine: a survey in Turkish gastroenterology patients.Distinct kinetics in the frequency of peripheral CD4+ T cells in patients with ulcerative colitis experiencing a flare during treatment with mesalazine or with a herbal preparation of myrrh, chamomile, and coffee charcoal.Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?Natural product-derived drugs for the treatment of inflammatory bowel diseases.Systematic review: Complementary and alternative medicine in the irritable bowel syndrome.Inflammatory bowel disease professionals' attitudes to and experiences of complementary and alternative medicineDoctor communication quality and Friends' attitudes influence complementary medicine use in inflammatory bowel diseaseComplementary and alternative medicine for functional gastrointestinal disorders.Review article: complementary and alternative therapies for inflammatory bowel disease.A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome.Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies.Andrographolide derivative AL-1 ameliorates TNBS-induced colitis in mice: involvement of NF-кB and PPAR-γ signaling pathways.Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.The Use of Complementary and Alternative Medicine among Patients with Inflammatory Bowel Disease Is Associated with Reduced Health-Related Quality of LifeComplementary and alternative medicines in irritable bowel syndrome: an integrative view.Use of complementary and alternative medicine by patients with inflammatory bowel disease.Complementary and alternative medicine in patients with inflammatory bowel disease: the results of a population-based inception cohort study (IBSEN).Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study.N-ECCO Consensus statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis.Use of Complementary and Alternative Medicine Among Dermatology Outpatients: Results From a National Survey.Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey.Complementary and Alternative Therapies for Functional Gastrointestinal Diseases.Complementary and Alternative Therapies for Functional Gastrointestinal Diseases 2016.Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease.Regional variations in the use of complementary and alternative medicines (CAM) for inflammatory bowel disease patients in Italy: an IG-IBD study.Therapeutic approach by Aloe vera in experimental model of multiple sclerosis.Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial.Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro.Digesters in traditional Persian medicine.Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic?Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study.Patterns of complementary and alternative medicine use in a population of pediatric patients with inflammatory bowel disease.A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome (IBS)
P2860
Q24669859-C522541D-587D-44BC-8FDB-B69E77F542F6Q26823835-C58E02D6-2416-4D45-85D0-E861B9685FB5Q26998841-3B82F711-9319-4B11-990A-8B1D87905CB6Q27004516-5BBE5D28-5322-4811-BA3E-78088B2D4754Q27022892-F6F9DFF1-8091-4086-B68F-F1C3B553B154Q28292798-F97DB928-BE72-41E5-813C-534E86B8AF89Q33512608-2CBDEF44-3EAB-4F3A-9100-AB143186F016Q34075201-CA73FBA5-3355-43E3-AACE-FE8905C29B5CQ34098643-1208FA87-3B47-4E91-8C5E-F60427F63D58Q34378678-52DF9235-E974-4370-B8F3-4B9DAF5A49C7Q34488888-7817B7AE-7523-4DEE-924E-927B82978777Q35064501-2F6AF240-289A-4AA9-A8E1-D28F93AB9825Q35221841-5FB71397-287F-4C41-93C3-8555B0CCECD5Q35760312-B56CEF7F-CA48-47DC-9A3E-95AEC85B702EQ36372525-928A5B2E-8D2D-4E71-BA78-CA348DDBE386Q36886282-5C4F7189-A45F-4310-AFDB-9F46FEF03AA8Q37019717-787ECABE-BD33-45B8-8688-2FBD9C772F08Q37110983-4A86CC5C-F76E-44D5-B36F-AABAC30F617DQ37312768-6977A54D-B6C8-49D4-9BB8-F844D4B7781EQ37492485-1B612D4B-E2CE-4699-8DF8-3313D4804AEEQ37581337-B12B15FF-72AB-4934-BEED-7E3F9D4E8BF6Q37789695-6499639A-E06F-4D21-91A8-26ADCA0E3926Q37992245-1B347F43-91F1-490B-B78E-CE6C4FA5B6F6Q38083493-78F35830-AFE2-40AD-ADC4-10DE581C928BQ38119781-7F747213-2830-4A81-82C8-0491B27ADB99Q39012645-3DAB2A6A-666D-4D11-864A-F2D414E02389Q40442352-ECF86FD3-AE2C-4506-8361-6CF0BED0EF71Q40745644-0D199A24-5E21-4BCB-A1DB-C1DB9BDB7749Q42347904-ED5131BB-9346-4F01-8467-F69CCE3249DEQ42641578-254653C5-B89E-4C53-AED9-DCD976AC8DD2Q42788674-0082F3A5-D9AD-424F-B79F-49431208AE72Q44376185-90F4C773-4460-47D7-AF18-9B97B0BA9F83Q44773472-77B67B47-AFB7-4BA1-A3B8-BCD15D06A4B6Q44778656-82770DEE-335F-40A5-B13A-42AF19F61E3DQ47550638-4603ACE1-1867-42F6-81BB-C71B67764B67Q50740990-10ADB70C-6F86-449C-A4D5-7A7D524E93C6Q51227314-1FFD12E3-73DC-4575-B877-2162B75E2C15Q53324592-F7799CE4-6727-4CA3-BFCE-2B48486905A2Q58702100-6457A079-6444-4796-8AC4-78D1D73CB929
P2860
Use of complementary therapies by patients with IBD may indicate psychosocial distress.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Use of complementary therapies by patients with IBD may indicate psychosocial distress.
@en
Use of complementary therapies by patients with IBD may indicate psychosocial distress.
@nl
type
label
Use of complementary therapies by patients with IBD may indicate psychosocial distress.
@en
Use of complementary therapies by patients with IBD may indicate psychosocial distress.
@nl
prefLabel
Use of complementary therapies by patients with IBD may indicate psychosocial distress.
@en
Use of complementary therapies by patients with IBD may indicate psychosocial distress.
@nl
P2093
P2860
P1476
Use of complementary therapies by patients with IBD may indicate psychosocial distress.
@en
P2093
David S Rampton
Louise Langmead
Meenali Chitnis
P2860
P304
P356
10.1097/00054725-200205000-00003
P577
2002-05-01T00:00:00Z